Mesh Bio
PrivateLast Round
Series A
Jan 30, 2024
Total Funding Raised
$5.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mesh Bio operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Series A round in January 2024.
Mesh Bio is a health technology company that provides a multidimensional health intelligence platform designed to transform chronic disease management through predictive analytics.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Medical AI, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Government Contracts, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mesh Bio Comparables
Compare Mesh Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prealize Health | 71% | |
| ClosedLoop | 63% | |
| Biofourmis | 63% |
For institutional investors. Book with your work email.
Mesh Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 30, 2024 | ||||
| Seed | Mar 10, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mesh Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SEEDS Capital | Series A, Seed |
| East Ventures | Series A |
| TAEL Partners | Seed |
| Elev8.vc | Series A, Seed |
| Citrine Capital Sdn Bhd | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 34% MoM, reaching 12.1K.
- Jun 17, 2026
Monthly visitors increased 179% MoM, reaching 9K.
For institutional investors. Book with your work email.
Mesh Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mesh Bio's valuation, stock price, and market status.
Is Mesh Bio a public or private company?
Mesh Bio is a private company.
What is the current stock price of Mesh Bio?
Mesh Bio is a private company, so its shares have no public market price. Caplight tracks Mesh Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mesh Bio worth (valuation)?
Valuation information for Mesh Bio is not publicly available.
Can I buy Mesh Bio stock?
Mesh Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mesh Bio's last funding round?
Mesh Bio's most recent funding round was Series A on January 30, 2024.
Who are the main investors in Mesh Bio?
Key investors in Mesh Bio include SEEDS Capital, East Ventures, Elev8.vc.
Will Mesh Bio IPO soon?
No public IPO plans have been announced for Mesh Bio.
How can I track Mesh Bio secondary market activity?
Caplight tracks bids, offers, and trades in Mesh Bio's shares on secondary markets.